Between the Beats

May 18, 2017

A new technology, bioelectric impedance cardiography (ZCG), which assesses blood flow in the chest to make inferences about heart function, may lead to a new way to identify heart problems. Now, with the help of the Health Sciences Emerging Scholars grant, George Washington University’s Josh Woolstenhulme, Ph.D., D.P.T., looks to prove the effectiveness of that technology.

Illustration of a man with computer

Woolstenhulme, an assistant professor in the Department of Physical Therapy and Health Care Sciences, explains that ZCG is different from traditional tools used to assess heart function because it relies on the electrical impedance of blood in the chest to determine how much blood is pumped out of the heart during each beat.

The primary focus of Woolstenhulme’s project is to validate the use of ZCG to assess diastolic function — the part of the heart cycle when the heart is between beats and filling with blood — while a patient is at rest, and while he or she is exercising. Validating the technology for this purpose might enable clinicians to better identify the presence of diastolic dysfunction.

Latest News

September 23, 2021
Celebrating the George Washington University bicentennial reflecting on the School of Medicine and Health Sciences’s (SMHS) 197 years at the university.
March 2, 2021
The George Washington University is participating in another COVID-19 vaccine clinical trial. GW was selected as one of approximately 25 sites in the United States to launch a Phase II study for the Sanofi COVID-19 adjuvanted recombinant protein-based COVID-19 vaccine candidate.
February 25, 2021
The George Washington University (GW) Office of the Vice President for Research and the GW School of Medicine and Health Sciences gave COVID-19 research a shot in the arm through the FY21 COVID-19 Research Fund competition.